Notch Inhibitor
Showing 1 - 25 of 7,454
Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma Trial in Boston (CB-103,
Not yet recruiting
- Adenoid Cystic Carcinoma
- +2 more
- CB-103
- +2 more
-
Boston, MassachusettsDana Farber Cancer Institute
Mar 14, 2023
Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma Trial in Houston (AL101, Therapeutic Conventional Surgery)
Recruiting
- Adenoid Cystic Carcinoma
- Metastatic Adenoid Cystic Carcinoma
- AL101
- Therapeutic Conventional Surgery
-
Houston, TexasM D Anderson Cancer Center
Jun 29, 2022
Salivary Gland Cancer, Metastatic, Advanced Trial in Toronto (Selinexor, EGFR or HER2 Inhibitor, FGFR Inhibitor)
Recruiting
- Salivary Gland Cancer
- +3 more
- Selinexor
- +6 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Feb 18, 2022
Desmoid Tumor, NOTCH Gene Mutation Positive Tumors Trial (Nirogacestat (Gamma Secretase Inhibitor))
Available
- Desmoid Tumor
- NOTCH Gene Mutation Positive Tumors
- Nirogacestat (Gamma Secretase Inhibitor)
- (no location specified)
Sep 7, 2021
Advanced Cancer Trial in Oklahoma City, Nashville (LY900009 - Dose Escalation Phase (Part A), LY900009 - Dose Confirmation Phase
Completed
- Advanced Cancer
- LY900009 - Dose Escalation Phase (Part A)
- LY900009 - Dose Confirmation Phase (Part B)
-
Oklahoma City, Oklahoma
- +1 more
Jun 27, 2019
Desmoid Tumors, Aggressive Fibromatosis Trial run by the NCI (PF-03084014)
Active, not recruiting
- Desmoid Tumors
- Aggressive Fibromatosis
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 14, 2022
Recurrent Melanoma, Stage IV Skin Melanoma Trial in New York (Cisplatin, Gamma-Secretase Inhibitor RO4929097, Laboratory
Completed
- Recurrent Melanoma
- Stage IV Skin Melanoma
- Cisplatin
- +5 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Oct 24, 2019
Lymphoblastic Leukemia, Acute T-cell, Precursor T-Cell Lymphoblastic Lymphoma Trial in France, Germany, United States
Completed
- Lymphoblastic Leukemia, Acute T-cell
- Precursor T-Cell Lymphoblastic Lymphoma
-
Boston, Massachusetts
- +5 more
Jul 29, 2019
Desmoid Tumor, Aggressive Fibromatosis Trial in Worldwide (Nirogacestat oral tablet, Placebo Oral Tablet)
Active, not recruiting
- Desmoid Tumor
- Aggressive Fibromatosis
- Nirogacestat oral tablet
- Placebo Oral Tablet
-
Little Rock, Arkansas
- +51 more
Jan 27, 2023
Shoulder Pain, Shoulder Impingement Syndrome Trial (ultrasound)
Not yet recruiting
- Shoulder Pain
- Shoulder Impingement Syndrome
- ultrasound
- (no location specified)
Aug 17, 2023
Lateral Femoral Impaction Fracture / Lateral Femoral Notch Sign
Recruiting
- Anterior Cruciate Ligament Injuries
- +2 more
- Measurements on knee MRI performed during routine clinical practice
-
Bełchatów, Łódzkie, PolandArtromedical Orthopaedic Clinic
Jan 4, 2023
Hypertension Trial in Dallas (KMgCit, Placebo)
Not yet recruiting
- Hypertension
- KMgCit
- Placebo
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Jul 26, 2022
Diffuse Large B Cell Lymphoma Trial in Shanghai (zanubrutinib)
Recruiting
- Diffuse Large B Cell Lymphoma
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Mar 13, 2022
Vascular Diseases Trial in Mar del Plata (Finger photoplethysmography)
Recruiting
- Vascular Diseases
- Finger photoplethysmography
-
Mar del Plata, Buenos Aires, Argentina
- +1 more
Jan 3, 2022
Tendinopathy Trial in Lyon (Endoscopic tenotomy surgery of the iliopsoas tendon)
Not yet recruiting
- Tendinopathy
- Endoscopic tenotomy surgery of the iliopsoas tendon
-
Lyon, FranceClinique de la Sauvegarde
Jul 17, 2023
Airway Management Trial in Brno (Laryngeal mask insertion)
Recruiting
- Airway Management
- Laryngeal mask insertion
-
Brno, South Moravian Region, CzechiaBrno University Hospital
Jan 31, 2022